9.2 MNT for Renal Diseases (AKI, CKD Stages 1-5, Dialysis, and Nephrotic Syndrome)

The kidneys maintain systemic homeostasis through the excretion of metabolic waste products, regulation of extracellular fluid volume and osmolality, maintenance of electrolyte and acid-base equilibrium, and secretion of essential hormones (erythropoietin, 1,25-dihydroxycholecalciferol / calcitriol, and renin). When renal functional mass declines, accumulation of nitrogenous waste (uremic toxins), hyperphosphatemia, hyperkalemia, secondary hyperparathyroidism, and fluid overload develop. Medical Nutrition Therapy is vital across all stages of renal disease to preserve residual nephron mass, prevent protein-energy wasting (PEW), and normalize biochemical parameters.

---

Renal Anatomy, Glomerular Filtration, and KDIGO CKD Staging

The functional unit of the kidney is the nephron, comprising the glomerulus (a high-pressure capillary network specialized for ultrafiltration) and a specialized tubular system (proximal convoluted tubule, loop of Henle, distal convoluted tubule, and collecting duct). The Glomerular Filtration Rate (GFR) expresses the volume of fluid filtered from the glomerular capillaries into Bowman's capsule per unit time and serves as the clinical index of functioning renal mass.

KDIGO Staging of Chronic Kidney Disease (CKD)

Under the Kidney Disease: Improving Global Outcomes (KDIGO) and National Kidney Foundation Kidney Disease Outcomes Quality Initiative (NKF KDOQI) guidelines, CKD is defined as abnormalities of kidney structure or function persisting for $> 3\text{ months}$:

---

MNT for Non-Dialysis Dependent Chronic Kidney Disease (Stages 3–5)

In pre-dialysis CKD, medical nutrition therapy seeks to retard the progression of renal failure, suppress the accumulation of uremic retention solutes (urea, guanidines, indoxyl sulfate, p-cresyl sulfate), and prevent protein-energy wasting:

1. Dietary Protein Prescription

• Target: $0.6 - 0.8\text{ g/kg/day}$ of dry/edema-free body weight (or $0.55 - 0.60\text{ g/kg/day}$ in metabolically stable, non-diabetic clients closely monitored by an RND).
• Protein Quality: At least 50% to 60% of total protein must be of High Biological Value (HBV) (eggs, poultry, fish, meat, dairy) to supply all essential amino acids while minimizing unnecessary non-essential nitrogen.
• Pathophysiological Rationale: High dietary protein intake induces vasodilation of the afferent glomerular arteriole, driving intraglomerular hypertension, capillary hyperfiltration, and accelerated glomerulosclerosis. Restricting protein reduces intraglomerular hydrostatic pressure, lowers proteinuria, and reduces hepatic production of nitrogenous uremic toxins.

2. Energy Requirements

• Target: $30 - 35\text{ kcal/kg/day}$ ($35\text{ kcal/kg/day}$ for individuals $< 60\text{ years}$; $30\text{ kcal/kg/day}$ for adults $\ge 60\text{ years}$ or sedentary).
• Clinical Rule: Providing adequate non-protein calories from complex carbohydrates and healthy unsaturated fats is mandatory. If energy intake falls below $30\text{ kcal/kg/day}$, endogenous somatic muscle is catabolized for energy, generating a spike in nitrogenous waste, worsening azotemia, and causing negative nitrogen balance.

3. Sodium and Fluid Balance

• Sodium: $1.5 - 2.3\text{ g/day}$ ($< 100\text{ mmol/day}$ or approx. $< 5.8\text{ g NaCl}$) to optimize blood pressure control and prevent extracellular volume expansion.
• Fluid: Unrestricted in Stages 1–3 if 24-hour urine output remains normal. In Stages 4–5 with oliguria or peripheral edema, restrict to $500 - 800\text{ mL/day} + \text{24-hour urine output}$.

4. Potassium Management

• Target: Usually unrestricted ($> 4{,}000\text{ mg/day}$) in Stages 1–3 unless serum potassium exceeds $5.0\text{ mEq/L}$. In Stages 4–5, restrict to $2.0 - 3.0\text{ g/day}$ ($50 - 75\text{ mEq/day}$) to prevent lethal cardiac arrhythmias.
• Dietary Strategies: Limit high-potassium fruits and vegetables (bananas, oranges, cantaloupe, dried fruits, potatoes, tomatoes, squash, spinach). Teach leaching techniques for tubers: peel, dice thinly, soak in large volumes of warm water for 2–4 hours, drain, and boil in fresh water.

5. Phosphorus and Calcium Equilibrium

• Phosphorus Target: $800 - 1{,}000\text{ mg/day}$ (or $< 10 - 12\text{ mg phosphorus per gram of dietary protein}$) when serum phosphorus or intact parathyroid hormone (iPTH) is elevated.
• Inorganic vs. Organic Phosphorus: Emphasize the elimination of processed foods containing inorganic phosphate additives (e.g., sodium tripolyphosphate, phosphoric acid in colas, canned meats, processed cheeses). Inorganic phosphate salts have an intestinal absorption rate of 90% to 100%, compared to organic plant phosphorus (phytates, 20% to 40% absorbed) and animal phosphorus (40% to 60% absorbed).
• Phosphate Binders: Calcium acetate, calcium carbonate, sevelamer hydrochloride/carbonate, lanthanum carbonate. Clinical Practice Rule: Phosphate binders must be ingested with meals and snacks to bind dietary phosphorus within the gastrointestinal lumen and prevent absorption.
• Calcium: Total elemental calcium (dietary intake plus calcium-based binders) must not exceed $800 - 1{,}000\text{ mg/day}$ to prevent extraskeletal metastatic vascular calcification.

---

Maintenance Hemodialysis (HD) vs. Peritoneal Dialysis (PD)

Upon initiation of maintenance dialysis, the clinical dietetic paradigm undergoes a dramatic shift. While pre-dialysis care requires protein restriction, maintenance dialysis requires a high-protein diet due to continuous amino acid and protein clearance into the dialysate:

Peritoneal Dialysate Dextrose Caloric Absorption Algorithm

Peritoneal dialysis solutions contain dextrose (1.5%, 2.5%, or 4.25%) as the osmotic agent. On average, 60% to 70% of the instilled dextrose is absorbed across the peritoneal membrane into the systemic circulation. Because commercial dialysate utilizes hydrous dextrose ($3.4\text{ kcal/g}$):

$\text{Total Dextrose Instilled (g)} = \text{Total Dialysate Volume (L)} \times [\text{Concentration (g/dL)} \times 10]$ $\text{Dextrose Absorbed (g)} = \text{Total Instilled (g)} \times 0.65$ $\text{Daily Energy from Dialysate (kcal)} = \text{Dextrose Absorbed (g)} \times 3.4\text{ kcal/g}$

$\text{Target Oral Caloric Intake} = \text{Total Estimated Energy Needs} - \text{Dialysate Calories}$

---

Acute Kidney Injury (AKI)

AKI is characterized by an abrupt decline in GFR (over hours to days) resulting in retention of nitrogenous waste and dysregulation of extracellular volume and electrolytes:

1. Etiological Classification

• Prerenal Azotemia: Renal hypoperfusion without structural parenchymal damage (hypovolemia, hemorrhage, septic vasodilation, decompensated heart failure). Characterized by a $\text{BUN}:\text{Serum Creatinine ratio} > 20:1$ and Fractional Excretion of Sodium ($\text{FeNa}$) $< 1\%$.
• Intrinsic (Renal) AKI: Direct structural damage to glomerular, tubular, or interstitial tissue (Acute Tubular Necrosis [ATN] from prolonged ischemia or nephrotoxins like aminoglycosides and radiocontrast; acute glomerulonephritis). $\text{BUN}:\text{Cr ratio} 10 - 15:1$; $\text{FeNa} > 2\%$.
• Postrenal AKI: Mechanical urinary tract obstruction distal to the kidney (prostatic hyperplasia, bilateral ureteral calculi, retroperitoneal tumor).

2. Clinical Phases

• Oliguric Phase: Urine output $< 400 - 500\text{ mL/day}$. Characterized by rapid azotemia, severe metabolic acidosis, hyperkalemia, hyperphosphatemia, and fluid retention.
• Diuretic Phase: Urine output surges to $> 1 - 3\text{ L/day}$ as tubular flow is restored while tubular epithelial concentrating ability remains impaired. Patients are at severe risk of hypovolemic dehydration, hypokalemia, and hyponatremia, requiring aggressive fluid and electrolyte repletion.

3. Protein Staging in AKI

• Non-catabolic, non-dialyzed AKI: $0.8 - 1.0\text{ g/kg/day}$.
• Moderately catabolic and/or intermittent HD: $1.2 - 1.5\text{ g/kg/day}$.
• Critically ill, hypercatabolic on Continuous Renal Replacement Therapy (CRRT): $1.5 - 2.0\text{ g/kg/day}$ (up to $2.5\text{ g/kg/day}$ in massive trauma or burns) to offset dialytic amino acid clearance and sustain somatic protein synthesis.

---

Nephrotic Syndrome

Nephrotic syndrome is caused by increased glomerular capillary permeability to plasma proteins due to damage to podocyte foot processes and the glomerular basement membrane:

• Pathognomonic Tetrad:
  1. Massive Proteinuria: $> 3.5\text{ g / 24 hours}$ (or $> 50\text{ mg/kg/day}$ in pediatric patients).
  2. Hypoalbuminemia: Serum albumin $< 3.0\text{ g/dL}$ (frequently $< 2.0\text{ g/dL}$).
  3. Generalized Edema (Anasarca): Decreased intravascular oncotic pressure shifts fluid into the interstitial space.
  4. Hyperlipidemia: Total cholesterol $> 250\text{ mg/dL}$, elevated LDL and VLDL. Hypoalbuminemia stimulates compensatory hepatic protein synthesis, unselectively upregulating hepatic synthesis of apolipoproteins while peripheral lipoprotein lipase (LPL) activity is suppressed.

• Sodium: Restrict to $1.5 - 2.0\text{ g/day}$ ($65 - 87\text{ mEq/day}$) to manage generalized peripheral edema.
• Lipid Management: Saturated fat $< 7\%$, elimination of trans fats, dietary cholesterol $< 200\text{ mg/day}$.

---

Medical Nutrition Therapy for Nephrolithiasis (Renal Calculi)

1. Calcium Oxalate Stones (75% to 80% of all calculi)

• Adequate Dietary Calcium Intake ($1{,}000 - 1{,}200\text{ mg/day}$): Clinical Rule: Do NOT restrict dietary calcium. Dietary calcium binds dietary oxalate within the gastrointestinal tract, forming an insoluble precipitate (calcium oxalate) that is excreted in feces. If dietary calcium is restricted, free unbound oxalate is absorbed across the intestinal mucosa into the bloodstream and cleared by the kidney, inducing hyperoxaluria, which dramatically accelerates stone formation.
• Dietary Oxalate Restriction: Restrict high-oxalate foods: spinach, beets, rhubarb, Swiss chard, star fruit (balimbing—which also contains deadly neurotoxins in renal failure), cocoa, nuts, black tea.
• Vitamin C Moderation: Avoid high-dose ascorbic acid supplements ($> 500\text{ mg/day}$), as ascorbic acid is metabolized into oxalate.
• Generous Hydration: Daily fluid intake $\ge 2.5 - 3.0\text{ L/day}$ to ensure daily urine volume $\ge 2.0 - 2.5\text{ L/day}$ and lower urinary solute concentration.

2. Uric Acid Stones (approx. 10% of calculi)

• Pathophysiology: Occur when urinary pH is persistently acidic ($\text{pH} < 5.5$), which precipitates insoluble un-ionized uric acid.
• MNT: Urine alkalinization (titrate to urinary $\text{pH } 6.5 - 7.0$) using potassium citrate or an alkaline ash diet (rich in vegetables, fruits, and fruit juices; low in meat, fish, and grains). Restrict dietary purines (organ meats, anchovies, sardines, meat extracts, yeast) to lower uric acid excretion.